𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BRCA1 and p53: compensatory roles in DNA repair

✍ Scribed by Anne-Renee Hartman; JamesM. Ford


Book ID
105796120
Publisher
Springer
Year
2003
Tongue
English
Weight
225 KB
Volume
81
Category
Article
ISSN
0946-2716

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Emerging roles of BRCA1 in transcription
✍ Yumay Chen; Wen-Hwa Lee; Helen K. Chew πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 206 KB πŸ‘ 2 views

BRCA1 was the first breast cancer susceptibility gene to be identified and cloned. In individuals from high-risk families, mutations in BRCA1 increase the lifetime risk of developing breast cancer eight to tenfold, compared to the general population. How the BRCA1 protein product normally functions

Abnormal expression of BRCA1 and BRCA1-i
✍ Kiyotsugu Yoshikawa; Tomoko Ogawa; Richard Baer; Hiromichi Hemmi; Kazuo Honda; A πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 513 KB

Breast cancer is one of the most common malignancies among women. The molecular mechanisms involved in breast carcinogenesis, however, remain to be elucidated. Although somatic mutation of BRCA1 is rare, BRCA1 protein expression is reduced in about 30% of sporadic breast carcinomas (Yoshikawa et al.

Breast cancer gene 1 (BRCA1): Role in ce
✍ Kumaravel Somasundaram πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 123 KB πŸ‘ 2 views

## Abstract Mutations of BRCA1 gene are associated with more than half the cases of hereditary breast cancer. Breast cancer formation in BRCA1 mutation carriers is generally accompanied by loss of the wild‐type allele, suggesting that BRCA1 protein may function as a tumor suppressor. The human BRCA

DNA repair gene polymorphisms and probab
✍ Mariana C. Stern; Kathleen Conway; Yu Li; Kusum Mistry; Jack A. Taylor πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

We investigated if the presence of single nucleotide polymorphisms (SNPs) in the XRCC1, XRCC3, and XPD genes were associated with the type and frequency of p53 mutations in bladder cancer. Using a hospital-based case-control study we have previously reported risks for the XRCC1 codon 194, XRCC1 codo